Lipocalin 2 Is Required for BCR-ABL-induced Tumorigenesis

Oncogene - United Kingdom
doi 10.1038/onc.2008.209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

IL-3 Receptor Signaling Is Dispensable for BCR-ABL-induced Myeloproliferative Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Oncogenic Ras-Induced Secretion of IL6 Is Required for Tumorigenesis

Genes and Development
GeneticsDevelopmental Biology
2007English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Adherence to BCR-ABL Inhibitors: Issues for CML Therapy

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2012English

Critical Role for Gab2 in Transformation by BCR/ABL

Cancer Cell
Cancer ResearchOncologyCell Biology
2002English

The Grb2 Binding Site Is Required for the Induction of Chronic Myeloid Leukemia-Like Disease in Mice by the BCR/Abl Tyrosine Kinase

Blood
BiochemistryImmunologyCell BiologyHematology
2000English

Kinase Domain Mutants of BCR Enhance BCR-Abl Oncogenic Effects

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy